Diagnostic Accuracy of Screening Tests and Treatment for Post-Acute Coronary Syndrome Depression: A Systematic Review.

Autor:	Nieuwsma JA; From Duke University School of Medicine, Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC), Durham Veterans Affairs Evidence Synthesis Center, Durham, North Carolina, and Southern California Permanente Medical Group, Anaheim, California; and University of Washington, Boise, Idaho., Williams JW Jr; From Duke University School of Medicine, Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC), Durham Veterans Affairs Evidence Synthesis Center, Durham, North Carolina, and Southern California Permanente Medical Group, Anaheim, California; and University of Washington, Boise, Idaho., Namdari N; From Duke University School of Medicine, Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC), Durham Veterans Affairs Evidence Synthesis Center, Durham, North Carolina, and Southern California Permanente Medical Group, Anaheim, California; and University of Washington, Boise, Idaho., Washam JB; From Duke University School of Medicine, Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC), Durham Veterans Affairs Evidence Synthesis Center, Durham, North Carolina, and Southern California Permanente Medical Group, Anaheim, California; and University of Washington, Boise, Idaho., Raitz G; From Duke University School of Medicine, Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC), Durham Veterans Affairs Evidence Synthesis Center, Durham, North Carolina, and Southern California Permanente Medical Group, Anaheim, California; and University of Washington, Boise, Idaho., Blumenthal JA; From Duke University School of Medicine, Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC), Durham Veterans Affairs Evidence Synthesis Center, Durham, North Carolina, and Southern California Permanente Medical Group, Anaheim, California; and University of Washington, Boise, Idaho., Jiang W; From Duke University School of Medicine, Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC), Durham Veterans Affairs Evidence Synthesis Center, Durham, North Carolina, and Southern California Permanente Medical Group, Anaheim, California; and University of Washington, Boise, Idaho., Yapa R; From Duke University School of Medicine, Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC), Durham Veterans Affairs Evidence Synthesis Center, Durham, North Carolina, and Southern California Permanente Medical Group, Anaheim, California; and University of Washington, Boise, Idaho., McBroom AJ; From Duke University School of Medicine, Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC), Durham Veterans Affairs Evidence Synthesis Center, Durham, North Carolina, and Southern California Permanente Medical Group, Anaheim, California; and University of Washington, Boise, Idaho., Lallinger K; From Duke University School of Medicine, Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC), Durham Veterans Affairs Evidence Synthesis Center, Durham, North Carolina, and Southern California Permanente Medical Group, Anaheim, California; and University of Washington, Boise, Idaho., Schmidt R; From Duke University School of Medicine, Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC), Durham Veterans Affairs Evidence Synthesis Center, Durham, North Carolina, and Southern California Permanente Medical Group, Anaheim, California; and University of Washington, Boise, Idaho., Kosinski AS; From Duke University School of Medicine, Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC), Durham Veterans Affairs Evidence Synthesis Center, Durham, North Carolina, and Southern California Permanente Medical Group, Anaheim, California; and University of Washington, Boise, Idaho., Sanders GD; From Duke University School of Medicine, Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC), Durham Veterans Affairs Evidence Synthesis Center, Durham, North Carolina, and Southern California Permanente Medical Group, Anaheim, California; and University of Washington, Boise, Idaho.
Jazyk:	angličtina
Zdroj:	Annals of internal medicine [Ann Intern Med] 2017 Nov 21; Vol. 167 (10), pp. 725-735. Date of Electronic Publication: 2017 Nov 14.
DOI:	10.7326/M17-1811
Abstrakt:	Background: Patients who have had an acute coronary syndrome (ACS) event have an increased risk for depression. Purpose: To evaluate the diagnostic accuracy of depression screening instruments and to compare safety and effectiveness of depression treatments in adults within 3 months of an ACS event. Data Sources: MEDLINE, EMBASE, PsycINFO, CINAHL, and Cochrane Database of Systematic Reviews from January 2003 to August 2017, and a manual search of citations from key primary and review articles. Study Selection: English-language studies of post-ACS patients that evaluated the diagnostic accuracy of depression screening tools or compared the safety and effectiveness of a broad range of pharmacologic and nonpharmacologic depression treatments. Data Extraction: 2 investigators independently screened each article for inclusion; abstracted the data; and rated the quality, applicability, and strength of evidence. Data Synthesis: Evidence from 6 of the 10 included studies showed that a range of depression screening instruments produces acceptable levels of diagnostic sensitivity, specificity, and negative predictive values (70% to 100%) but low positive predictive values (below 50%). The Beck Depression Inventory-II was the most studied tool. A large study found that a combination of cognitive behavioral therapy (CBT) and antidepressant medication improved depression symptoms, mental health-related function, and overall life satisfaction more than usual care. Limitation: Few studies, no evaluation of the influence of screening on clinical outcomes, and no studies addressing several clinical interventions of interest. Conclusion: Depression screening instruments produce diagnostic accuracy metrics that are similar in post-ACS patients and other clinical populations. Depression interventions have an uncertain effect on cardiovascular outcomes, but CBT combined with antidepressant medication produces modest improvement in psychosocial outcomes. Primary Funding Source: Agency for Healthcare Research and Quality (PROSPERO: CRD42016047032).
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu